|
|
||||||||
Ann Thorac Surg 2004;77:1179-1182
© 2004 The Society of Thoracic Surgeons
a Department of Obstetrics and Gynecology, Sakai Hospital, Kinki University School of Medicine, Osaka, Japan
b Department of Obstetrics and Gynecology, University of Tsukuba, Ibaraki, Japan
c Saitama Cancer Center, Saitama, Japan
d National Kyushu Cancer Center, Fukuoka, Japan
e Aichi Cancer Center Hospital, Aichi, Japan
f National Cancer Center, Tokyo, Japan
g Kurume University Hospital, Fukuoka, Japan
Accepted for publication June 13, 2003.
* Address reprint requests to Dr Yamamoto, Department of Obstetrics and Gynecology, Sakai Hospital, Kinki University School of Medicine, 2-7-1, Harayamadai, Sakai, Osaka 590-0132, Japan
e-mail: yamamoto{at}sakai.med.kindai.ac.jp
BACKGROUND: This study evaluated the results of resection of pulmonary metastases from cervical cancer.
METHODS: A total of 7,748 patients with primary stage Ib or II cervical cancer underwent curative initial treatment consisting of radical hysterectomy or radiotherapy in 22 hospitals. Of the 7,748 patients, 29 (0.37%) patients had pulmonary metastases, which were detected after a disease-free period after initial treatment (radical hysterectomy or radiotherapy) and were resected with the intention to cure by June 30, 1998.
RESULTS: The 5-year disease-free survival rate after pulmonary metastasectomy for all patients was 32.9%. Patients with one or two pulmonary metastases had a 5-year disease-free survival rate of 42.2% compared with 0% for patients with three or four metastases (p = 0.0003). Patients with squamous cell cancers had a 5-year disease-free survival rate of 47.4% compared with 0% for patients with adenosquamous cell cancers or adenocarcinoma (p = 0.0141). On multivariate analysis, the significant prognostic variables for disease-free survival were two or fewer metastases (p = 0.0232) and squamous cell cancer (p = 0.0168).
CONCLUSIONS: Cervical cancer patients with pulmonary metastases after initial treatment (radical hysterectomy or radiotherapy) could expect to achieve long-term disease-free survival by pulmonary metastasectomy when there are two or fewer metastases diagnosed as squamous cell cancer.
This article has been cited by other articles:
![]() |
J. M. Clavero, C. Deschamps, S. D. Cassivi, M. S. Allen, F. C. Nichols III, B. A. Barrette, D. R. Larson, and P. C. Pairolero Gynecologic Cancers: Factors Affecting Survival After Pulmonary Metastasectomy Ann. Thorac. Surg., June 1, 2006; 81(6): 2004 - 2007. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |